US Patent Issued to Allergan Pharmaceuticals International on June 23 for "Methods of treating migraine" (New Jersey Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,341, issued on June 23, was assigned to Allergan Pharmaceuticals International Ltd. (Dublin). "Methods of treating migraine" was invented b... Read More

US Patent Issued to GT GAIN THERAPEUTICS on June 23 for "Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase" (Spanish, Swiss Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,342, issued on June 23, was assigned to GT GAIN THERAPEUTICS SA (Lugano, Switzerland). "Heteroaryl compounds and therapeutic uses thereof i... Read More

US Patent Issued to Societe des Produits Nestle on June 23 for "Compositions containing nicotinamide and vitamin B6 and methods of using such compositions for promoting muscle growth" (Swiss Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,343, issued on June 23, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland). "Compositions containing nicotinamide and vi... Read More

US Patent Issued to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo., SHANGHAI BAOLONG PHARMACEUTICAL, BAOLONG PHARMACEUTICAL, SHANGHAI BAOLONG ANQING PHARMACEUTICAL on June 23 for "Safe and stable nimodipine formulation for injection and method for preparing same" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,344, issued on June 23, was assigned to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGYCo. LTD. (Shanghai), SHANGHAI BAOLONG PHARMACEUTICAL Co.... Read More

US Patent Issued to THE GEORGE INSTITUTE FOR GLOBAL HEALTH on June 23 for "Compositions for the treatment of hypertension" (Australian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,345, issued on June 23, was assigned to THE GEORGE INSTITUTE FOR GLOBAL HEALTH (Randwick, Australia). "Compositions for the treatment of hy... Read More

US Patent Issued to SIMCERE PHARMACEUTICAL on June 23 for "Anti-aging method comprising applying JWA gene" (Chinese Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,346, issued on June 23, was assigned to SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing, China). "Anti-aging method comprising applying JWA gene" ... Read More

US Patent Issued to Dr. Falk Pharma on June 23 for "Systemic formulation of a pyridinone derivate for coeliac disease" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,347, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany). "Systemic formulation of a pyridinone derivate for coelia... Read More

US Patent Issued to Dr. Falk Pharma, Zedira on June 23 for "Systemic formulation of a pyridinone derivate for TG2-related diseases" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,348, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany) and Zedira GmbH (Darmstadt, Germany). "Systemic formulatio... Read More

US Patent Issued to LG CHEM on June 23 for "Pharmaceutically acceptable salt of sphingosine-1-phosphate receptor agonist, and crystalline form thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,349, issued on June 23, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Pharmaceutically acceptable salt of sphingosine-1-phosphate rec... Read More

US Patent Issued to Flex Pharma on June 23 for "Amorphous cabozantinib particles and uses thereof" (Minnesota Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,350, issued on June 23, was assigned to Flex Pharma LLC (New Brighton, Minn.). "Amorphous cabozantinib particles and uses thereof" was inve... Read More

• ««
• «
• 3228
• 3229
• 3230
• 3231
• 3232
• 3233
• 3234
• 3235
• 3236
• 3237
• »
• »»